{
  "abstract": "Starting in late 2021, cases of paediatric acute hepatitis of unknown origin (AHUO) surged in frequency, coinciding with a reduction in pandemic lockdown measures. Patients tested negative for hepatotropic viruses A-E and lacked other common causes of acute hepatitis.1 The highest incidence was reported in the UK, Europe and the USA, particularly among children under the age of 6 years.1 A subset of patients developed acute liver failure, with around 6% of children requiring transplantation.2",
  "authors": [
    {
      "affiliations": [
        "Department of Gastroenterology and Hepatology, Campus Charité Mitte and Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany"
      ],
      "name": "Isabella Lurje"
    },
    {
      "affiliations": [
        "Department of Gastroenterology and Hepatology, Campus Charité Mitte and Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany"
      ],
      "name": "Frank Tacke"
    }
  ],
  "title": "Immune pathology in paediatric acute hepatitis of unknown origin — uncovering the link to COVID-19",
  "uid": "357b856d-5cc8-53b2-a3cb-01ed698c5087"
}